Protonix Injection, Powder, For Solution
Product Images NDC 0008-4001

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Protonix (NDC 0008-4001). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Wyeth Pharmaceuticals Llc, A Subsidiary Of Pfizer Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Protonix 01)

FDA Label Image

Pfizer Logo (Protonix 02)

FDA Label Image

Principal Display Panel (40 mg Vial Label)

Principal Display Panel (40 mg Vial Label)
PROTONIX®LV (pantoprazole sodium) is a medication available in single-dose vial with 40mg/vial. It is sterile and should be administered only through intravenous infusion. The medication is Rx only and requires reconstitution. The package insert should be consulted for proper dosage and administration. The medication should be stored at a temperature range of 20°C to 25°C with excursions to 15°C to 30°C allowed. Wyeth Pharmaceuticals LLC distributes the medication under license from Takeda GmbH, Germany. PremierPTOR® is a registered trademark of Premier Healthcare Alliance, LP.*
FDA Label Image

Principal Display Panel (40 mg Vial Carton)

Principal Display Panel (40 mg Vial Carton)
PROTONIX® LV (pantoprazole sodium) for injection is a sterile medication intended for intravenous infusion only. Each single-dose vial contains 40 mg/vial of pantoprazole sodium, equivalent to 45.1 mg of pantoprazole. The medication contains 1 mg edetate disodium, and no filter is required. PROTONIX® LV is distributed by Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer, Inc. and is protected from light. The recommended storage temperature is 20°-25°C (68°-77°F) with excursions permitted to 15°-30°C (59°-86°F). The package insert contains information on dosage and administration. The medication is manufactured by Takeda GmbH in Germany. PREMIERProRx® is a registered trademark of Premier Healthcare Alliance, LP, used under license.*
FDA Label Image

Principal Display Panel (10 Unit Carton Bundle Label)

Principal Display Panel (10 Unit Carton Bundle Label)
Each vial contains 40mg of Pantoprazole sodium and 1mg Edetate disodium. The vial should be stored at 20°-25°C and protected from light. It is recommended to use the vial carton. The product is distributed by Wyeth Pharmaceuticals LLC and made in France. It is a single-dose vial for intravenous infusion only. The NDC is 0008-4001-10, and the product contains ten unit cartons. The trademark used is PREMIERProRx®.*
FDA Label Image

Principal Display Panel (25 Vial Carton)

Principal Display Panel (25 Vial Carton)
PROTONIX®LV is a medication for injection containing 40mg of pantoprazole sodium. It is distributed by Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc, in Philadelphia. Made in France, each vial contains 40mg of pantoprazole and is protected from light. Premier Healthcare Alincs LP's PREMIERProRx® is a registered trademark used under license. The rest of the text seems to be providing information about the manufacturer and storage conditions of the medication.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.